Big Money Rotating Out Of Health Care As Q4 Begins (XLV)

healthcare
Analyst/ETF Trader Paul Weisbruch of Street One Financial brings us his daily fund flows update, which today points out big demand in ex-U.S. equities, a sector rotation out of some key sector funds, and bullish bets on financials ahead of earnings reports in the space next week.
NYSE:XLV October 4, 2017 11:42am

Biotech Was The Hottest ETF Sector In The Third Quarter (IBB)

pills-drugs-biotech1
From Zacks: The broader market was pretty eventful in the third quarter. While geopolitical and political concerns were rife, those threats couldn't weigh on the equity market returns.
NASDAQ:IBB October 3, 2017 10:09am

Positive Biotech Sentiment Takes Hold (IBB)

pills-drugs-biotech1
From Buzz Indexes: A common question we field relates to the transmission mechanism of sentiment to the share price: "How long does it take / when will it be reflected?"
NASDAQ:IBB July 6, 2017 2:58pm

It Might Be Time To Buy Pharmaceuticals (PJP)

white-pills
From Invesco: The pharmaceutical industry has lagged in recent years, due in part to political uncertainty, which has kept a lid on company share prices.
NYSE:PJP

Examining Niche Plays In The Biotech ETF Space (PBE)

pills-drugs-biotech4
We spoke about Biotech stocks on Monday and the torrid performance in the sector since mid-June, and the largest sector ETF in the space IBB (iShares Nasdaq Biotechnology, Expense Ratio 0.47%) continues to pack in assets in the near term.
NYSE:PBE June 29, 2017 2:10pm

Health Care SPDR ETF (XLV) Options Indicate A Possible Major Pullback

pills-drugs-biotech1
The options market is sending a bearish signal about the Health Care SPDR ETF (NYSE:XLV) right now, and the suddenly high-flying fund might be due for a major short-term pullback.
NYSE:XLV

Health Care Investors Should Brace For Impact (XLV)

Medical Device
From Invesco: Commanding much attention last week was the release of the Senate’s version of the American Health Care Act, which was recently passed by the House.
NYSE:XLV June 27, 2017 6:10am

iShares NASDAQ Biotechnology Index ETF (IBB) Suddenly Looks Bullish

biotech-white-pills
It has been some time since we last spoke about the Biotech Equity segment in this piece, as the sector was simply not a solid performer through much of 2016 and has only recently come to life here in mid-2017.
NASDAQ:IBB June 26, 2017 11:50am

Health Care (XLV) Finally Breaks Out To The Bullish Side

healthcare
From Dana Lyons: As other sectors stumble, health care stocks are finally hitting new all-time highs again after two long years.
NYSE:XLV June 21, 2017 6:23am

Pharmaceuticals (PJP) Won’t Be The Only Sector Hurt By Legal Pot

medical-marijuana
From Bill Hall: In my most recent Money and Markets articles, I’ve put you on the inside track about a rapidly growing, yet mostly still under-the-radar, industry. One that the world’s super-rich are quietly funding with their own money, in pursuit of potentially eye-popping investment returns.
NYSE:PJP June 19, 2017 6:12am

How Medical Marijuana Will Disrupt The Pharmaceutical Industry (VHT)

medical-marijuana
From Bill Hall: In my last two Money and Markets articles, I’ve put you on the inside track when I revealed that “family offices” — the preferred investment platforms for many of the world’s mega-millionaires and billionaires — are quietly funding the rapidly growing legal marijuana business.
NYSE:VHT June 10, 2017 7:22am

Building A Truly Diversified Portfolio Is Much Easier Said Than Done

pie-chart
From Steven Vannelli, CFA: There are three basic ways to manage the risk of an equity portfolio, which you'll find below.
NYSE:XLV June 9, 2017 10:55am

What’s Next For Biotech Stocks? (IBB)

biotech-white-pills
From Franklin Templeton Investments: Changing political policies and priorities can impact certain market sectors—for better or worse. Health care costs and prescription drug pricing were hot-button issues in the United States during the 2016 presidential election, and the Trump administration has been pushing forward its own health care agenda.
NASDAQ:IBB June 7, 2017 5:57am

Biotech Firms, NIH Team Up To Stop Trump’s Research Budget Cuts

biotech-medical-pills
The CEOs of several prominent biotech companies joined forces with the head of the National Institutes of Health (NIH) today in Washington to try and convince the White House not to seek major budget reductions for medical research.
NASDAQ:IBB May 8, 2017 4:17pm

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular


From Our Partners


Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories